首页> 外文期刊>Health and Quality of Life Outcomes >Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia
【24h】

Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia

机译:EORCC QLQ-C30和QLQ-BR23模块的Amharic版本的可靠性和有效性,用于评估埃塞俄比亚乳腺癌患者健康相关生活质量的模块

获取原文
获取外文期刊封面目录资料

摘要

BACKGROUND:Breast cancer is the most common cancer among women and it affects quality of life of those women. So far, the two most frequently used tools for assessing health related quality of life in breast cancer patients, EORTC QLQ-C30 and EORTC QLQ-BR23 modules, were not validated in Ethiopia. Hence, the present study aimed to assess?the psychometric properties of the tools among Ethiopian breast cancer patients.METHODS:Institutional based longitudinal study was conducted from January 1 to May 1, 2017 GC at only nationwide oncology center, Tikur Anbessa Specialized Hospital (TASH), Addis Ababa, Ethiopia. A total of 146 patients who visited the facility during that period, with no missing quality of life data, were selected for analysis. The psychometric properties of the EORTC QLQ-C30 and EORTC QLQ-BR23 were evaluated in terms of reliability, convergent, divergent, construct and clinical validity using SPSS version 22.RESULTS:Satisfactory internal consistency reliability (Cronbach's α coefficients ?0.7) was confirmed, except for cognitive function (α?=?0.516) of EORTC QLQ-C30 and body image (α?=?0.510) of EORTC QLQ-BR23. Multiple-trait scaling analysis demonstrated a good convergent and divergent validity. No scaling errors were observed. Most items in EORTC QLQ-BR23 possessed a weak or no correlation with its own dimension in EORTC QLQ-C30 (r??0.4) except with some of symptom scales. A statistically significant chemotherapy induced quality of life scores changes (P?≤?0.05) were observed in all dimensions of both instruments between baseline and the end of first cycle chemotherapy, except for body image (P?=?0.985) and sexual enjoyment (P?=?0.817) of EORTC QLQ-BR23, indicating clinical validity.CONCLUSION:Amharic version of the EORTC QLQ-C30 and EORTC QLQ-BR23 modules are valid and adequately reliable tool and can be used for clinical and epidemiological cancer researches to study the health related quality of life (HRQoL) of women with breast cancer in Ethiopia.
机译:背景:乳腺癌是女性中最常见的癌症,它会影响那些女性的生活质量。到目前为止,埃塞俄比亚未经验证,两种最常用的用于评估健康相关生活质量的乳腺癌患者生活质量的工具,在埃塞俄比亚未验证。因此,本研究旨在评估埃塞俄比亚乳腺癌患者中工具的心理测量特性。方法:机构基于机构的纵向研究于2017年1月1日至5月1日至2017年5月1日才在唯一一个全国肿瘤学中心,Tikur Anbessa专业医院(Tash ),埃塞俄比亚亚的斯亚贝巴。选择在此期间访问该设施的146名患者,没有缺少生活质量数据,以进行分析。使用SPSS版本22的可靠性,收敛,分歧,构造和临床有效性评估EORTC QLQ-C30和EORTC QLQ-BR23的心理测量特性。结果:令人满意的内部一致性可靠性(Cronbach的α系数>?0.7)被确认,除了EORTC QLQ-C30的认知函数(αα= 0.516)和EORCC QLQ-BR23的主体图像(α?= 0.510)。多种特征缩放分析表明了良好的会聚和发散的有效性。没有观察到缩放错误。除了一些症状尺度之外,EORTC QLQ-BR23中的大多数项目都具有弱且与其自身的维度相关的相关性。在基线和第一循环化疗结束之间的所有尺寸的所有尺寸中,观察到统计学上显着的化疗诱导的生命质量分数(p?≤≤0.05),除了身体形象(p?= 0.985)和性享受( P?=β0.817)EORCC QLQ-BR23,表明临床有效性。结论:EORCC QLQ-C30和EORTC QLQ-BR23模块的Amharic版本有效且充分可靠的工具,可用于临床和流行病学癌症研究埃塞俄比亚乳腺癌患有乳腺癌的健康相关质量(HRQOL)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号